Pages that link to "Q48396522"

The following pages link to Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke (Q48396522):

Displaying 14 items.

• Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (Q28388335) (← links)
• Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents (Q28583852) (← links)
• Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion (Q34126249) (← links)
• Alternative activation-skewed microglia/macrophages promote hematoma resolution in experimental intracerebral hemorrhage. (Q34554517) (← links)
• Delayed combination therapy of local brain hypothermia and decompressive craniectomy on acute stroke outcome in rat. (Q34567097) (← links)
• Nuclear receptors and inflammatory diseases (Q37122891) (← links)
• PPAR Regulation of Inflammatory Signaling in CNS Diseases (Q37231755) (← links)
• PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury (Q37362740) (← links)
• Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review. (Q37801966) (← links)
• Modulators of microglia: a patent review (Q38685760) (← links)
• Neuroprotective consequences of postconditioning on embolic model of cerebral ischemia in rat. (Q42274295) (← links)
• Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. (Q46074706) (← links)
• Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats (Q46970970) (← links)
• Genistein: mechanisms of action for a pleiotropic neuroprotective agent in stroke (Q48003821) (← links)